Medicus Pharma Ltd.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
Ontario, Canada
Business Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN, PA, 19428
Mailing Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN, PA, 19428
Phone
610-540-7515
Fiscal Year End
1231
EIN
981778211
Financial Overview
FY2025
-$11.16M
Net Income
$10.06M
Total Assets
$10.02M
Total Liabilities
$8.71M
Cash & Equivalents
$-1.16
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
Annual Reports
10-K
March 25, 2026
- Positive interim Phase 2 data for SkinJect showed 60% lesion clearance with no serious side effects.
- FDA provided a clearer, accelerated path to Phase 3 trials, potentially saving 12-18 months.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.